carfilzomib

Ukraine

Drugs containing this active substance

  • CORLISA

    The drug is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior course of anti-tumor therapy. It is used in combination with daratumumab and dexamethasone, lenalidomide and dexamethasone, or with dexamethasone alone.

    Form: powder for solution for infusion

    Active substance Dosage
    carfilzomib 60 mg

    ATC: L01XG02

    Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7